Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PORTER, R. J.
Right arrow Articles by LACY, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PORTER, R. J.
Right arrow Articles by LACY, J. R.
NEUROLOGY 1977;27:1006
© 1977 American Academy of Neurology

Diagnostic and therapeutic reevaluation of patients with intractable epilepsy

ROGER J. PORTER, M.D., J. KlFFlN PENRY, M.D. and JOSEPH R. LACY, M.D.

Epilepsy Branch, Neurological Disorders Program, National Instituteof Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.

Intensive monitoring techniques were used to improve seizure diagnosis and control in 23 patients with intractable epilepsy: (1) Video recording of clinical seizures and the ictal EEG, (2) long-term telemetered EEG recordings, and (3) frequent determination of plasma antiepileptic drug concentrations. Patients were monitored in the hospital for an average of 8 weeks and after discharge were followed for an average of 8 months. At follow-up, 70 percent of the patients continued to have improved seizure control as compared with baseline studies, 83 percent had decreased toxicity, and about half had made gains in social adjustment. Use of the techniques described can make a significant contribution to patients previously considered intractable to therapy.

Reprint requests should be addressed to Dr. Porter, Epilepsy Branch, Federal Building, Room 114, NINCDS, Bethesda, MD 20014.

Presented in part at the twenty-eighth annual meeting of the American Academy of Neurology, April 26-May 1, 1976, Toronto, Canada.

Accepted for publication April 1977.




This article has been cited by other articles:


Home page
NEJMHome page
M. J. Brodie and M. A. Dichter
Antiepileptic Drugs
N. Engl. J. Med., January 18, 1996; 334(3): 168 - 175.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1977 by AAN Enterprises, Inc.